Document is current
Any future updates will be listed below
-
Authors
Chang, Daniel H. https://orcid.org/0000-0001-6307-6342
Kao, Andrew A.
Huggins, Laura K.
Albert, Jacqueline N.
Whinery, Jacqueline N.
Camirand, Brittany M.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06567834 at ClinicalTrials.govDocuments that mention this clinical trial
Clinical Evaluation of Violet Light Filtration and High-Resolution Lathing on a Diffractive Extended Depth of Focus IOL
https://doi.org/10.1007/s40123-024-01056-0
-
Funding
Funding for this research was provided by:
Johnson and Johnson Vision Care (DHC-1258)
- License Information
-
More Information
Article History
Received: 15 August 2024
Accepted: 11 October 2024
First Online: 25 October 2024
Declarations
:
: Daniel H. Chang, MD is an investigator and consultant for Johnson & Johnson Vision and an investigator for Beaver-Visitec International and Ocuphire. Andrew A. Kao, MD is an investigator for Glaukos Corp, Johnson & Johnson Vision and Beaver-Visitec International. Laura K. Huggins, OD in an investigator for Glaukos Corp, Johnson & Johnson Vision, Ocuphire and Beaver-Visitec International. Jacqueline N. Albert, OD in an investigator for Glaukos Corp, Johnson & Johnson Vision, Ocuphire and Beaver-Visitec International. Jacqueline N. Whinery, CCRC, COA and Brittany M. Camirand, COT have no competing interests to disclose.
: This study was approved by the regulatory and institutional review board, Salus IRB, and was conducted in accordance with the US Code of Federal Regulations, the Declaration of Helsinki, ISO 14155:2011, and all other applicable laws and regulations. All patients provided written informed consent and gave health information access authorization in accordance with HIPAA guidelines prior to participating in the study.
